Short description
Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
Description
Inhalon Biopharma is into developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Carrboro, North Carolina, United States, North America
Founded on
October 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access, Uh Ohhhh, Nopepepe, Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Samuel Lai, Thomas Moench